SESSION XIV: NEXT QUESTIONS

Session Chairs: Guillermo Garcia-Manero and Phillip Scheinberg 

Next Questions: Acute Lymphoblastic Leukemia | Bijal D Shah, MD | Moffitt Cancer Center, Tampa, Florida, USA

Next Questions: Acute Myeloid Leukemia | Farhad Ravandi, MD | MD Anderson Cancer Center, Houston, Texas, USA

Next Questions: Cellular Therapy | Koen van Besien, MD, PhD | UH Seidman Cancer Center, Cleveland, Ohio, USA

Next Questions: Chronic Lymphocytic Leukemia | Thomas Kipps, MD, PhD | UC San Diego Moores Cancer Center, La Jolla, California, USA

Next Questions: Chronic Myeloid Leukemia | Timothy P Hughes, MD, MBBS | South Australian Health and Medical Research Institute, Adelaide, Australia

Next Questions: Aggressive B-Cell Lymphoma | Mark J Roschewski, MD | NCI Center for Cancer Research, Bethesda, Maryland, USA

Next Questions: Indolent B-Cell Lymphoma | Laurie H Sehn, MD, MPH | BC Cancer Agency, Vancouver, Canada

Next Questions: T-Cell Lymphoma | Barbara Pro, MD | Columbia University, New York, New York, US

Next Questions: Mantle Cell Lymphoma | Michael Wang, MD | MD Anderson Cancer Center, Houston, Texas, USA

Next Questions: Hodgkin Lymphoma | Alison J Moskowitz, MD | Memorial Sloan Kettering Cancer Center, New York, New York, USA

Next Questions: Multiple Myeloma | Noopur Raje, MD | Massachusetts General Hospital, Boston, Massachusetts, USA

Next Questions: Myelodysplastic Syndromes | Gullermo Garcia-Manero, MD | MD Anderson Cancer Center, Houston, Texas, USA

Next Questions: Myeloproliferative Neoplasms | Jason R Gotlib, MD, MS | Stanford Cancer Institute, Stanford, California, USA

Closing Remarks | Drawing | Gullermo Garcia-Manero, MD | President, Society of Hematologic Oncology